A new AI-powered, imaging-based technology that creates accurate three-dimensional models of tumors, veins and other soft tissue offers a promising new method to help surgeons operate on, and better treat, breast cancers.
The technology, from Illinois-based startup SimBioSys, converts routine black-and-white MRI images into spatially accurate, volumetric images of a patient's breasts. It then illuminates different parts of the breast with distinct colors - the vascular system, or veins, may be red; tumors are shown in blue; surrounding tissue is gray.
Surgeons can then easily manipulate the 3D visualization on a computer screen, gaining important insight to help guide surgeries and influence treatment plans. The technology, called TumorSight Viz, calculates key surgery-related measurements, including a tumor's volume and how far tumors are from the chest wall and nipple.
It also provides key data about a tumor's volume in relation to a breast's overall volume, which can help determine - before a procedure begins - whether surgeons should try to preserve a breast or choose a mastectomy, which often presents cosmetic and painful side effects. Last year, TumorSight received FDA clearance.
Across the world, nearly 2.3 million women are diagnosed with breast cancer each year, according to the World Health Organization. Every year, breast cancer is responsible for the deaths of more than 500,000 women. Around 100,000 women in the U.S. annually undergo some form of mastectomy, according to the Brigham and Women's Hospital.
According to Jyoti Palaniappan, chief commercial officer at SimBioSys, the company's visualization technology offers a step-change improvement over the kind of data surgeons typically see before they begin surgery.
Typically, surgeons will get a radiology report, which tells them, Here's the size and location of the tumor,' and they'll get one or two pictures of the patient's tumor, said Palaniappan. If the surgeon wants to get more information, they'll need to find the radiologist and have a conversation with them - which doesn't always happen - and go through the case with them.
Dr. Barry Rosen, the company's chief medical officer, said one of the technology's primary goals is to uplevel and standardize presurgical imaging, which he believes can have broad positive impacts on outcomes.
We're trying to move the surgical process from an art to a science by harnessing the power of AI to improve surgical planning, Dr. Rosen said.
SimBioSys uses NVIDIA A100 Tensor Core GPUs in the cloud for pretraining its models. It also uses NVIDIA MONAI for training and validation data, and NVIDIA CUDA-X libraries including cuBLAS and MONAI Deploy to run its imaging technology. SimBioSys is part of the NVIDIA Inception program for startups.
SimBioSys is already working on additional AI use cases it hopes can improve breast cancer survival rates.
It has developed a novel technique to reconcile MRI images of a patient's breasts, taken when the patient is lying face down, and converts those images into virtual, realistic 3D visualizations that show how the tumor and surrounding tissue will appear during surgery - when a patient is lying face up.
This 3D visualization is especially relevant for surgeons so they can visualize what a breast and any tumors will look like once surgery begins.
To create this imagery, the technology calculates gravity's impact on different kinds of breast tissue and accounts for how different kinds of skin elasticity impact a breast's shape when a patient is lying on the operating table.
The startup is also working on a new strategy that also relies on AI to quickly provide insights that can help determine the risk of recurrence to support providers in determining the best treatment to avoid cancer recurrence.
Currently, hospital labs run pathology tests on tumors that surgeons have removed. The biopsies are then sent to a different outside lab, which conducts a more comprehensive molecular analysis.
This process routinely takes up to six weeks. Without knowing how aggressive a cancer in the removed tumor is, or how that type of cancer might respond to different treatments, patients and doctors are unable to quickly chart out treatment plans to avoid recurrence.
SimBioSys's new technology uses an AI model to analyze the 3D volumetric features of the just-removed tumor, the hospital's initial tumor pathology report and a patient's demographic data. From that information, SimBioSys generates - in a matter of hours - a risk analysis for that patient's cancer, which can help doctors quickly determine the best treatment to avoid recurrence.
According to SimBioSys's Palaniappan, the startup's new method matches or exceeds the risk of recurrence scoring ability of more traditional methodologies, based upon its internal studies. It also takes a fraction of the time of these other methods while costing far less money.
Most recent headlines
11/12/2025
Dalet, a leading provider of cloud-native, end-to-end media workflow solutions, ...
20/11/2025
LONDON The winners of the Rise Awards 2025, which recognize women and companies whose achievements have stood out in the media technology industry, have been an...
20/11/2025
SANTA MONICA & NEW YORK Lionsgate's Worldwide Television Distribution Group and Debmar-Mercury have launched MovieSphere Gold in more than 30 million homes....
20/11/2025
ALAMEDA, Calif. Clear-Com has introduced its four-channel HelixNet beltpack, a next-generation advancement of its widely used two-channel model, and anticipates...
20/11/2025
NEW PROVIDENCE, N.J. Streaming technology and services provider Kiswe has launched Kiswe Core, a next-generation cloud-based platform designed to simplify the s...
20/11/2025
MOUNTAIN VIEW, Calif. Dolby Laboratories has signed on as an official signature partner of the Bay Area Host Committee (BAHC) for the 2026 Super Bowl and the we...
20/11/2025
STUTTGART, Germany 3 Screen Solutions (3SS) has announced that the Canadian multiservice operator Telus has launched its Telus TV+ entertainment platform on Sam...
20/11/2025
Major League Baseball has announced deals with ESPN, NBCUniversal and Netflix covering 2026-2028 that make ESPN the exclusive rightsholder of MLB.TV, see regula...
20/11/2025
Berklee Presents Holiday Extravaganza: Duke Ellingtons The Nutcracker Suite and ...
20/11/2025
The How To Gael pocast gals, comedian Chris Kent and quizzer Darragh Ennis drop by for the fifth episode of The 2 Johnnies Late Night Lock In
In the penultimat...
20/11/2025
Tonight on RT Prime Time, Marie Crowe on how a Reading School changed her son&#...
20/11/2025
The NVIDIA Blackwell RTX upgrade is nearing the finish line, letting GeForce NOW Ultimate members across the globe experience true next-generation cloud gaming ...
20/11/2025
Tanya Berger-Wolf's first computational biology project started as a bet wit...
19/11/2025
Sphere Sound Kicks Up Its Heels at Radio City Music HallUltra-immersive system from the singular Las Vegas venue is also ready for sportsBy Dan Daley, Audio Edi...
19/11/2025
The Future of Stadium and Arena Video Control Rooms: Tech Leaders Talk 4K, IP, a...
19/11/2025
One Year at Intuit Dome: Walking Through the Stunning Arena's Advanced Video...
19/11/2025
SVG Sit-Down: IMG's Francois Westcombe Goes Inside IMG's Annual Digital ...
19/11/2025
Inside Brighton & Hove Albion's fan-first media machine By George Bevir
Tuesday, November 18, 2025 - 10:10
Print This Story
Brighton & Hove Albion'...
19/11/2025
Rock Chalk Rebuild, Part 1: Kansas Athletics Brings New Production Power to Rebu...
19/11/2025
Rock Chalk Rebuild, Part 2: A Pro's Guide to Kansas Athletics' New Video...
19/11/2025
MLB Media Rights Shakeup: NBC Inks Three-Year Deal for Sunday Night Baseball, Pe...
19/11/2025
Rohan Parashuram Kanawade attends the premiere of Sabar Bonda (Cactus Pears) at the 2025 Sundance Film Festival at Egyptian Theatre on January 26, 2025, in Pa...
19/11/2025
Awards season is heating up, and the International Documentary Association just ...
19/11/2025
Aerojet Rocketdyne President Ken Bedingfield and Arkansas Gov. Sarah Huckabee Sanders were joined by state and local officials to celebrate the groundbreaking o...
19/11/2025
L3Harris and PentenAmio formalise their teaming agreement at MilCIS 2025, streng...
19/11/2025
Calrec gives Phoenix Broadcast Solutions its full support in strategic multi-year enterprise partnership New Singapore OB company invests in Calrec technology f...
19/11/2025
October brings a larger audience in front of TV screens. The cooler autumn weather and the continuation of new programming schedules brought increases in both t...
19/11/2025
IRVING, Texas Nexstar Media Group and Tegna filed applications on Nov. 18 with the Federal Communications Commission (FCC) seeking its consent to transfer broad...
19/11/2025
Vitec has acquired Datapath, a developer of real-time video processing for large-scale video walls, AVoIP content distribution and KVM control in mission-critic...
19/11/2025
NEVADA CITY, Calif. Telestream has introduced ARGUS Version 2.3, which introduces Live Look, a feature that lets operators inspect live and on-demand streams vi...
19/11/2025
STAMFORD, Conn. and NEW YORK Charter Communications, Inc. has announced a major deal with Amazon Web Services (AWS) that establishes AWS as one of Charters stra...
19/11/2025
TOKYO Atomos has announced a major firmware update that brings integrated camera control to the Ninja TX GO and Ninja TX its new CFexpress-based monitor-recor...
19/11/2025
Berklee's Signature Series Reimagines the Musical and Visual Artistry of Col...
19/11/2025
PlayBox Neo departed the NAB Show New York 2025 on a high note. The company's all-new PlayBox Neo Suite made a splash on the show floor, drawing strong inte...
19/11/2025
AAVBR (American Audio Visual Baton Rouge), a leading full-service event production company serving Louisiana and the Gulf Coast region, has enhanced its product...
19/11/2025
In its mission to deliver live event services combining advanced engineering with a creative approach to captivating live sports and entertainment experiences, ...
19/11/2025
NEW YORK Short-form vertical video has exploded across platforms like TikTok, Instagram and YouTube, but a new survey commissioned by Media.net, a provider of c...
19/11/2025
NEW YORK YES Network, the regional sports network home of the New York Yankees and Brooklyn Nets, and CAMB.AI have struck a partnership they said will leverage ...
19/11/2025
WASHINGTON The Federal Communications Commission has issued detailed guidance on filings that were disrupted by the government shutdown. While many of those fil...
19/11/2025
NEW YORK The popularity of NFL games is largely responsible for continued seasonal momentum in TV viewership into October (measured Sept. 29-Oct. 26), according...
19/11/2025
DirecTV has announced that its MyFree DirecTV streaming service has added seven new channels. Those include four sports services, NBA FAST, Red Bull TV, DAZN Ri...
19/11/2025
SURREY, U.K. Mark Roberts Motion Control (MRMC) has launched Flair Bridge, a compact device that transforms how operators control the company's motion-contr...
19/11/2025
WASHINGTON The Federal Communications Commission, which is continuing to rapidly ramp up its operations after the end of the federal government shutdown, has se...
19/11/2025
IRVING, Texas Nexstar Media Group and Tegna filed applications on Nov. 18 with the Federal Communications Commission (FCC) seeking its consent to transfer broad...
19/11/2025
Martin Freeman, Jessie Buckley, Wu-Tang Clan's Raekwon, Eddie the Eagle and ...
19/11/2025
Rohde & Schwarz collaborates with Broadcom to enable testing and validation of n...
19/11/2025
Back to All News
Innato, starring Imanol Arias and Elena Anaya, arrives on Netf...
19/11/2025
Back to All News
Guillermo del Toro Sits Down With Troll 2 Director Roar Uthaug...
19/11/2025
Some projects feel monumental from the moment the first phone call comes in. When BCE, the host broadcaster appointed to coordinate the national coverage, asked...
A new AI-powered, imaging-based technology that creates accurate three-dimensional models of tumors, veins and other soft tissue offers a promising new method to help surgeons operate on, and better treat, breast cancers.
